Oncternal Therapeutics, Inc. (ONCT)

NASDAQ: ONCT · IEX Real-Time Price · USD

8.52

-0.48 (-5.33%)

At close: May 7, 2024, 4:00 PM

8.94

+0.42 (4.93%)

After-hours: May 7, 2024, 4:46 PM EDT

Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Cash & Equivalents	6.7	37.14	90.77	116.74	20.05	20.65	15.82	8.91	14.06	17.88	Upgrade
Short-Term Investments	27.56	26.58	0	0	0	0	28.08	12.96	15.2	31.42	Upgrade
Cash & Cash Equivalents	34.26	63.72	90.77	116.74	20.05	20.65	43.9	21.87	29.26	49.3	Upgrade
Cash Growth	-46.24%	-29.79%	-22.25%	482.20%	-2.88%	-52.97%	100.74%	-25.25%	-40.65%	234.68%	Upgrade
Other Current Assets	1.8	3.57	2.09	1.27	0.74	0.57	2.18	2.43	2.63	0.86	Upgrade
Total Current Assets	36.06	67.29	92.85	118	20.79	21.21	46.08	24.3	31.89	50.15	Upgrade
Property, Plant & Equipment	0.26	0.09	0.08	0.04	0.19	0	0.05	0.08	0.01	0.03	Upgrade
Goodwill and Intangibles	0	0	0	0	0	0	0.11	0.12	0.14	0.47	Upgrade
Other Long-Term Assets	0.41	1.27	0.66	0.77	0.77	0.75	0	0	0	0	Upgrade
Total Long-Term Assets	0.67	1.36	0.73	0.81	0.96	0.75	0.16	0.2	0.14	0.5	Upgrade
Total Assets	36.73	68.65	93.59	118.81	21.74	21.96	46.24	24.5	32.03	50.65	Upgrade
Accounts Payable	1.15	2.92	1.96	1.14	0.87	3.44	2.6	1.22	0.38	0.51	Upgrade
Deferred Revenue	0	0	0	1.63	3.64	0	0	0	0	0	Upgrade
Current Debt	0.17	0.09	0.08	0.04	0.1	0	0	0	0	0	Upgrade
Other Current Liabilities	3.88	4.68	3.43	3.04	2.73	0.89	5.37	3.39	29.79	32.28	Upgrade
Total Current Liabilities	5.2	7.68	5.47	5.86	7.34	4.33	7.98	4.61	30.17	32.79	Upgrade
Long-Term Debt	0.15	0	0	0	0.09	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	1.33	0	0	0	0	47.26	0	0	0	0.03	Upgrade
Total Long-Term Liabilities	1.48	0	0	0	0.09	47.26	0	0	0	0.03	Upgrade
Total Liabilities	6.68	7.68	5.47	5.86	7.43	51.59	7.98	4.61	30.17	32.82	Upgrade
Total Debt	0.32	0.09	0.08	0.04	0.19	0	0	0	0	0	Upgrade
Debt Growth	265.52%	16.00%	87.50%	-78.95%	-	-	-	-	-	-	Upgrade
Retained Earnings	-197.78	-158.3	-114.13	-82.8	-65.57	-31.38	-561.64	-531.2	-513.47	-494.77	Upgrade
Comprehensive Income	0	0.01	0	0	0	0	0	0	0	0	Upgrade
Shareholders' Equity	30.05	60.97	88.12	112.95	14.31	-29.63	38.26	19.89	1.86	17.83	Upgrade
Net Cash / Debt	33.94	63.64	90.69	116.7	19.86	20.65	43.9	21.87	29.26	49.3	Upgrade
Net Cash / Debt Growth	-46.67%	-29.83%	-22.29%	487.57%	-3.80%	-52.97%	100.74%	-25.25%	-40.65%	234.68%	Upgrade
Net Cash Per Share	11.54	24.20	36.78	114.94	38.46	114.98	352.38	210.28	277.17	843.60	Upgrade
Working Capital	30.86	59.61	87.39	112.15	13.45	16.88	38.1	19.69	1.72	17.36	Upgrade
Book Value Per Share	10.22	23.18	35.73	111.25	27.71	-165.03	307.12	191.27	18.54	305.11	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).